All news

Cardlytics Q3 miss masks 10-20% Q4 billings growth guide

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Cardlytics (CDLX) experienced Q3 results that fell short due to a one-time U.K. bank disruption and cautious advertiser budgets. Despite this, the company expanded its reach through new advertiser growth and CRP partnerships. For Q4, Cardlytics anticipates a 10%–20% sequential billings growth, signaling a guided return to sequential growth.

Read original source

CDLX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.